These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38853532)

  • 1. Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancer.
    Edwards DM; Pirzadeh M; Van T; Jiang R; Tate A; Schaefer G; James J; Bishop C; Wilson C; Nedzesky N; Alseri A; Leveque A; Malus A; Waljee A; Elliott DA; Deng J; Schwartz A; Schipper M; Bryant AK; Ramnath N; Green MD
    Cancer; 2024 Sep; 130(17):2910-2917. PubMed ID: 38853532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to Lung Cancer Screening in the Veterans Health Administration: Does Geographic Distribution Match Need in the Population?
    Boudreau JH; Miller DR; Qian S; Nunez ER; Caverly TJ; Wiener RS
    Chest; 2021 Jul; 160(1):358-367. PubMed ID: 33617804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Receipt of Positron Emission Tomography-Computed Tomography With Non-Small Cell Lung Cancer Mortality in the Veterans Affairs Health Care System.
    Vella M; Meyer CS; Zhang N; Cohen BE; Whooley MA; Wang S; Hope MD
    JAMA Netw Open; 2019 Nov; 2(11):e1915828. PubMed ID: 31747036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to Follow-up Testing Recommendations in US Veterans Screened for Lung Cancer, 2015-2019.
    Núñez ER; Caverly TJ; Zhang S; Glickman ME; Qian SX; Boudreau JH; Slatore CG; Miller DR; Wiener RS
    JAMA Netw Open; 2021 Jul; 4(7):e2116233. PubMed ID: 34236409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
    Su CT; Bhargava A; Shah CD; Halmos B; Gucalp RA; Packer SH; Ohri N; Haramati LB; Perez-Soler R; Cheng H
    Clin Lung Cancer; 2018 Sep; 19(5):e767-e773. PubMed ID: 29937386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of Lung Cancer Screening in the Veterans Health Administration.
    Kinsinger LS; Anderson C; Kim J; Larson M; Chan SH; King HA; Rice KL; Slatore CG; Tanner NT; Pittman K; Monte RJ; McNeil RB; Grubber JM; Kelley MJ; Provenzale D; Datta SK; Sperber NS; Barnes LK; Abbott DH; Sims KJ; Whitley RL; Wu RR; Jackson GL
    JAMA Intern Med; 2017 Mar; 177(3):399-406. PubMed ID: 28135352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration.
    Lillie SE; Fu SS; Fabbrini AE; Rice KL; Clothier B; Nelson DB; Doro EA; Moughrabieh MA; Partin MR
    Lung Cancer; 2017 Feb; 104():38-44. PubMed ID: 28212998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Veterans Health Administration Structured Data to Identify Patients Eligible for Lung Cancer Screening.
    Gundle K; Hooker ER; Golden SE; Shull S; Crothers K; Melzer AC; Slatore CG
    Mil Med; 2023 Jul; 188(7-8):e2419-e2423. PubMed ID: 36722178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
    Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
    CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.
    Gierada DS; Pinsky PF
    Chest; 2021 Feb; 159(2):862-869. PubMed ID: 32822676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association Between Primary Source of Healthcare Coverage and Colorectal Cancer Screening Among US Veterans.
    May FP; Yano EM; Provenzale D; Neil Steers W; Washington DL
    Dig Dis Sci; 2017 Aug; 62(8):1923-1932. PubMed ID: 28528373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Implementation of Lung Cancer Screening at One Veterans Affairs Medical Center.
    Okereke IC; Bates MF; Jankowich MD; Rounds SI; Kimble BA; Baptiste JV; Ng TT; Nici LL
    Chest; 2016 Nov; 150(5):1023-1029. PubMed ID: 27568228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of Video-Assisted Thoracoscopic Lung Resections Within the Veterans Affairs for Known or Suspected Lung Cancer.
    Maiga AW; Deppen SA; Denton J; Matheny ME; Gillaspie EA; Nesbitt JC; Grogan EL
    JAMA Surg; 2019 Jun; 154(6):524-529. PubMed ID: 30865221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Cancer Screening in Clinical Practice: A 5-Year Review of Frequency and Predictors of Lung Cancer in the Screened Population.
    Lafata KJ; Read C; Tong BC; Akinyemiju T; Wang C; Cerullo M; Tailor TD
    J Am Coll Radiol; 2024 May; 21(5):767-777. PubMed ID: 37952807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Cancer Survival Trends in the Veterans Health Administration.
    Moghanaki D; Taylor J; Bryant AK; Vitzthum LK; Sebastian N; Gutman D; Burns A; Huang Z; Lewis JA; Spalluto LB; Williams CD; Sullivan DR; Slatore CG; Behera M; Stokes WA
    Clin Lung Cancer; 2024 May; 25(3):225-232. PubMed ID: 38553325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
    Williams CD; Alpert N; Redding TS; Bullard AJ; Flores RM; Kelley MJ; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):112-118. PubMed ID: 31624076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose Computed Tomography Screening.
    Vachani A; Carroll NM; Simoff MJ; Neslund-Dudas C; Honda S; Greenlee RT; Rendle KA; Burnett-Hartman A; Ritzwoller DP
    J Thorac Oncol; 2022 Dec; 17(12):1355-1364. PubMed ID: 36087860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Observed Harms and Expected Mortality Benefit for Persons in the Veterans Health Affairs Lung Cancer Screening Demonstration Project.
    Caverly TJ; Fagerlin A; Wiener RS; Slatore CG; Tanner NT; Yun S; Hayward R
    JAMA Intern Med; 2018 Mar; 178(3):426-428. PubMed ID: 29356812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.